Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)

PHASE3CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Head and Neck Cancer
Interventions
DRUG

carboplatin

Given IV

DRUG

cisplatin

Given IV

DRUG

docetaxel

Given IV

DRUG

fluorouracil

Given IV

Trial Locations (15)

10461

Albert Einstein Cancer Center at Albert Einstein College of Medicine, The Bronx

15232

UPMC Cancer Centers, Pittsburgh

21201

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore

30322

Winship Cancer Institute of Emory University, Atlanta

33486

Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus, Boca Raton

60153

Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

80224

CCOP - Colorado Cancer Research Program, Denver

92093-0658

Rebecca and John Moores UCSD Cancer Center, La Jolla

04074

Maine Center for Cancer Medicine and Blood Disorders - Scarborough, Scarborough

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

03756-0002

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon

07103

UMDNJ University Hospital, Newark

28232-2861

Blumenthal Cancer Center at Carolinas Medical Center, Charlotte

D-60590

Klinikum der J.W. Goethe Universitaet, Frankfurt

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT00095875 - Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) | Biotech Hunter | Biotech Hunter